Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Changes in serum lipoprotein(a) in hyperlipidemic subjects undergoing long-term treatment with lipid-lowering drugs
Adrian S. Dobs
, Mukesh Prasad
,
Anne Goldberg
, Marcella Guccione
, Donald R. Hoover
Institute of Clinical and Translational Sciences (ICTS)
Division of Endocrinology, Metabolism & Lipid Research
Research output
:
Contribution to journal
›
Article
›
peer-review
18
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Changes in serum lipoprotein(a) in hyperlipidemic subjects undergoing long-term treatment with lipid-lowering drugs'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Atherosclerotic Vascular Disease
12%
Atorvastatin
62%
Cholestyramine
62%
High-density Lipoprotein Cholesterol (HDL-C)
12%
Inconsistency
12%
Lipid-lowering Drugs
100%
Lipoproteins
100%
Lipoproteins LDL
12%
Long-term Treatment
100%
Lovastatin
62%
Low-density Lipoprotein
12%
Low-density Lipoprotein Cholesterol (LDL-C)
25%
Minimal Impact
12%
Multicenter Clinical Trial
12%
Placebo
12%
Plasma Lipoproteins
12%
Serum Lipids
12%
Serum Lipoproteins
100%
Triglycerides
12%
Pharmacology, Toxicology and Pharmaceutical Science
Antilipemic Agent
100%
Clinical Trial
12%
Colestyramine
62%
High Density Lipoprotein
12%
Hyperlipidemia
100%
Lipoprotein A
100%
Low Density Lipoprotein
12%
Mevinolin
62%
Placebo
12%
Pravastatin
62%
Triacylglycerol
12%
Vascular Disease
12%